Xenon Pharmaceuticals XENE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's enterprise value?
- Xenon Pharmaceuticals (XENE) reported enterprise value of $5.01B in Q1 2026.
- How has Xenon Pharmaceuticals's enterprise value changed year-over-year?
- Xenon Pharmaceuticals's enterprise value increased by 103.7% year-over-year, from $2.46B to $5.01B.
- What is the long-term trend for Xenon Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's enterprise value has grown at a 34.2% compound annual growth rate (CAGR), from $751.75M to $3.27B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.